Current Opinion in Biotechnology

Current Opinion in Biotechnology is a subscription (hybrid open access) journal published by Elsevier BV in the United Kingdom. OpenAlex counts 6,152 works from it, cited 468,487 times; its h-index is 307. Its two-year mean citedness, which is computed the way the impact factor is, is 8.77: a paper it published in the two years before was cited about 8.77 times last year. It published 124 papers in 2025, down 14% from 145 in 2024. Publishing a paper open access in it costs about US$4,530.

Publisher
Elsevier BV
Citations per paper
8.77 two-year mean, OpenAlex
h-index
307 i10-index 3,815
Access
Subscription · hybrid open access
APC
US$4,530 to publish open access
ISSN
0958-1669, 1879-0429
Country
United Kingdom
Works published
6,152 cited 468,487 times
Papers in 2025
124
Field
Biochemistry, Genetics and Molecular Biology
Website
Journal home ↗

Current Opinion in Biotechnology year by year

Papers it published each year, and the citations all its papers received that year.

YearPapers publishedCitations received
2026 so far13124,787
202512427,834
202414529,080
202315128,285
202217127,719
202122028,184
202017326,872
201917924,678

What Current Opinion in Biotechnology publishes

Its most frequent research topics, by OpenAlex's topic classification.

Questions about Current Opinion in Biotechnology

What is the impact factor of Current Opinion in Biotechnology?

Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 8.77 for Current Opinion in Biotechnology: on average, each paper it published in the two years before was cited about 8.77 times in a year.

What is the h-index of Current Opinion in Biotechnology?

307, by OpenAlex's count: 307 of its papers have each been cited at least 307 times. Its i10-index is 3,815.

Is Current Opinion in Biotechnology open access?

Not fully. Current Opinion in Biotechnology is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.

What is the publication fee (APC) of Current Opinion in Biotechnology?

About US$4,530, which is the fee to publish a paper open access as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.

What is the ISSN of Current Opinion in Biotechnology?

Its linking ISSN is 0958-1669; all its ISSNs: 0958-1669, 1879-0429.

Who publishes Current Opinion in Biotechnology?

Elsevier BV, based in the United Kingdom.

How many papers does Current Opinion in Biotechnology publish a year?

124 in 2025, by OpenAlex's count of what it published that year.

What does Current Opinion in Biotechnology publish?

Its most frequent research topics are Microbial Metabolic Engineering and Bioproduction, Enzyme Catalysis and Immobilization, Gene Regulatory Network Analysis, in the field of Biochemistry, Genetics and Molecular Biology.

Is Current Opinion in Biotechnology a predatory journal?

Nothing in the scholarly indexes suggests so. Current Opinion in Biotechnology is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 6,152 works cited 468,487 times. For a journal you do not know, check the red flags with our predatory journal checker.

Is Current Opinion in Biotechnology indexed in Scopus or Web of Science?

Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (0958-1669): both are free to search. Our guide on checking journal indexing shows each step.

Journals like Current Opinion in Biotechnology

Other Biochemistry, Genetics and Molecular Biology journals with a similar impact.

Every Biochemistry, Genetics and Molecular Biology journal, ranked · The journal directory

Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).